Putative mechanisms for vascular damage by homocysteine

被引:89
作者
Bellamy, MF [1 ]
McDowell, IFW [1 ]
机构
[1] UNIV WALES COLL MED, DEPT BIOCHEM MED, CARDIOVASC SCI RES GRP, CARDIFF CF4 4XN, S GLAM, WALES
关键词
D O I
10.1023/A:1005377310872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In homocystinuria homocysteine appears to be directly toxic to the vasculature, but in mild hyperhomocysteinaemia a cause and effect relationship remains unproven. Evidence for a causal role is derived from recent primate and human studies in which endothelial dysfunction was produced by modestly elevated blood homocysteine concentrations. Endothelial dysfunction would account for an increased risk of both arterial and venous disease. A key abnormality may be impaired release and/or action of nitric oxide in response to flow. Other possible mechanisms include smooth muscle cell proliferation, extracellular matrix modification and lipoprotein oxidation. Although demonstrated in vitro, a role for lipoprotein oxidation in man has not been substantiated. However an effect of homocysteine on cellular redox status remains a possible mechanism. Homocysteine does not appear to alter circulating coagulation factors consistently, but may promote enhanced thrombin production indirectly by its effects on endothelium. Further studies are required to elucidate the pathological actions of homocysteine, concentrating on the effects of mild hyper-homocysteinaemia on endothelial function in man.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 37 条
[1]   SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE [J].
ARNESEN, E ;
REFSUM, H ;
BONAA, KH ;
UELAND, PM ;
FORDE, OH ;
NORDREHAUG, JE .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) :704-709
[2]  
BELLAMY MF, 1996, J INHER METAB DIS S1, V19, P23
[3]   LIPID-PEROXIDATION AND SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO IN-VITRO OXIDATION IN HYPERHOMOCYSTEINAEMIA [J].
BLOM, HJ ;
KLEINVELD, HA ;
BOERS, GHJ ;
DEMACKER, PNM ;
HAKLEMMERS, HLM ;
POELEPOTHOFF, MTWBT ;
TRIJBELS, JMF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (03) :149-154
[4]   Homocysteine mediated endothelial cell toxicity and its amelioration [J].
Blundell, G ;
Jones, BG ;
Rose, FA ;
Tudball, N .
ATHEROSCLEROSIS, 1996, 122 (02) :163-172
[5]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[6]   Endothelial dysfunction in atherosclerosis [J].
Busse, R ;
Fleming, I .
JOURNAL OF VASCULAR RESEARCH, 1996, 33 (03) :181-194
[7]   IMPAIRED ENDOTHELIAL FUNCTION OCCURS IN THE SYSTEMIC ARTERIES OF CHILDREN WITH HOMOZYGOUS HOMOCYSTINURIA BUT NOT IN THEIR HETEROZYGOUS PARENTS [J].
CELERMAJER, DS ;
SORENSEN, K ;
RYALLS, M ;
ROBINSON, J ;
THOMAS, O ;
LEONARD, JV ;
DEANFIELD, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (03) :854-858
[8]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[9]   HUMAN ARTERIAL ENDOTHELIAL-CELL DETACHMENT INVITRO - ITS PROMOTION BY HOMOCYSTEINE AND CYSTEINE [J].
DUDMAN, NPB ;
HICKS, C ;
WANG, J ;
WILCKEN, DEL .
ATHEROSCLEROSIS, 1991, 91 (1-2) :77-83
[10]   CIRCULATING LIPID HYDROPEROXIDE LEVELS IN HUMAN HYPERHOMOCYSTEINEMIA - RELEVANCE TO DEVELOPMENT OF ARTERIOSCLEROSIS [J].
DUDMAN, NPB ;
WILCKEN, DEL ;
STOCKER, R .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (04) :512-516